Literature DB >> 7484643

MR and positron emission tomography with fludeoxyglucose F 18 in gliomatosis cerebri.

M A Dexter1, G D Parker, M Besser, J Ell, M J Fulham.   

Abstract

A 16-year-old girl presented with a unilateral third nerve palsy and predominant gray matter involvement on MR and positron emission tomography with fludeoxyglucose F 18. These findings were manifestations of gliomatosis cerebri. The antemortem diagnosis was made by partial temporal lobectomy.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7484643      PMCID： PMC8338084     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  5 in total

1.  Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri.

Authors:  Stanley Yang; Stephan Wetzel; M Law; D Zagzag; Soonmee Cha
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

2.  MR spectroscopy in gliomatosis cerebri.

Authors:  M Bendszus; M Warmuth-Metz; R Klein; R Burger; C Schichor; J C Tonn; L Solymosi
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

3.  Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography.

Authors:  N Sato; T Inoue; K Tomiyoshi; J Aoki; N Oriuchi; A Takahashi; T Otani; H Kurihara; T Sasaki; K Endo
Journal:  Neuroradiology       Date:  2003-09-13       Impact factor: 2.804

4.  Gliomatosis cerebri mimicking encephalitis evaluated using fluorine-18 fluorodeoxyglucose: Positron emission tomography/computed tomography.

Authors:  Koramadai Karuppusamy Kamaleshwaran; Vijayan Krishnan; Vyshakh Mohanan; Deepu Shibu; Ajit Sugunan Shinto
Journal:  Indian J Nucl Med       Date:  2015 Jan-Mar

Review 5.  Gliomatosis Cerebri: Current Understanding and Controversies.

Authors:  Surabhi Ranjan; Katherine E Warren
Journal:  Front Oncol       Date:  2017-08-07       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.